Delivery Order 36C25221D0074-36C25223N0037
- Not listed
- This is a delivery order contract awarded to Caredx, Inc., a for-profit medical diagnostics company based in Brisbane, California. The contract is for the provision of AlloSure kidney testing kits, which are used to assess organ rejection risk in transplant patients. The contract has a total ceiling value of $2,045,340.00 and was awarded by the U.S. Department of Veterans Affairs (VA) through its Veterans Integrated Service Network (VISN) 12. The contract has a performance period ending on...
- The federal contract award is for laboratory services provided by Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California. The contract, valued at $241,463.75, was awarded by the U.S. Department of Veterans Affairs (VA) to Caredx for the delivery of advanced genetic and molecular testing solutions focused on organ transplant diagnostics. The contract, which has a completion date of January 14, 2026, is a Firm Fixed Price Delivery Order, with no set-aside...
- This federal contract award to Caredx, Inc., a for-profit medical testing company, is for the provision of specialized genetic testing services to support organ transplant programs for the U.S. Department of Veterans Affairs (VA). The contract, valued at $529,760.00, is a delivery order awarded under a larger Indefinite Delivery Vehicle (IDV) contract with a $1,963,141.20 ceiling for genetic blood testing services. Caredx will supply the VA with its AlloSure kidney and heart tests, AlloMap heart...
- This federal contract award is for the provision of TRANSPLANT TESTING KITS by Caredx, Inc., a for-profit organization that specializes in advanced medical testing products and services to support organ transplant programs. The contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA), has a ceiling value of $2,397,593.00 and is structured as a Delivery Order on a Firm Fixed Price basis. The contract does not have a set-aside...
- This federal contract award is for "TRANSPLANT LABORATORY TESTING" services provided by Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services to support organ transplant programs. The contract, valued at $205,530.69, was awarded by the Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 9 (VISN 9). The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) contract valued at...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a purchase order valued at approximately $2,842 to Caredx, Inc. doing business as Caredx of Brisbane, California. The firm fixed price contract is to provide ALLOSURE KIDNEY TESTS from September 5-8, 2023 in support of VHA's healthcare programs for veterans. Caredx will deliver the requested medical products to aid in diagnosis and treatment. No subcontractors or set aside...
- This federal contract award is for the provision of genetic blood testing services for transplant patients, specifically the AlloMap and AlloSure testing products, to the U.S. Department of Veterans Affairs (VA). The contract was awarded to Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California, that specializes in advanced diagnostic solutions for organ transplant patients. The contract has a ceiling value of $643,166.71 and is a Firm Fixed Price Delivery...
- CareDx, Inc. was awarded a $247,578.50 firm fixed price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 6 on October 19, 2022, for AlloSure kidney donor-derived cell-free DNA testing kits. The contract, which carries no set-aside designation, has an ultimate completion date of October 18, 2027, and is performed in Brisbane, California. The solicitation sought quotes for AlloSure Kidney Donor-Derived Cell-Free DNA Testing services to support the...
- Caredx, Inc., a Brisbane, California-based medical technology company specializing in advanced diagnostic solutions for organ transplant patients, was awarded a delivery order valued at $142,037.50 by Veterans Integrated Service Network (VISN) 23 on January 15, 2026. The contract, which carries an ultimate completion date of January 14, 2028, is for AlloSure in-home patient testing services and operates under firm fixed pricing without a set-aside designation. The work will be performed in...
- This is a federal contract award from the Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit organization that specializes in providing advanced medical testing products and services to support organ transplant programs. The contract, valued at $127,833.75, is for laboratory services related to Caredx's AlloSure kidney and heart tests, AlloMap heart tests, and other genetic blood testing services for transplant patients. The contract is a definitive contract with a firm fixed...
- 36C25221D0074Indefinite Delivery Contract
- 36C25221D0074-36C25223N0037Delivery Order
This federal contract award to Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California, is for the provision of AlloSure kidney testing kits. The award, valued at $676,098.50, is a delivery order contract with a firm fixed price pricing type. The contracting agency is the Department of Veterans Affairs (VA) and the specific VA entity is Veterans Integrated Service Network 12 (VISN 12). The contract is not designated as a set-aside. Caredx has been awarded multiple federal contracts, including two significant Indefinite Delivery Vehicle (IDV) contracts with the VA for genetic blood testing services, including AlloMap and AlloSure products to assess organ rejection risks in transplant patients. This AlloSure kidney testing contract appears to be part of the VA's ongoing utilization of Caredx's specialized transplant diagnostic services across its healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | $76.7k | 12/12/23 | |
| Not listed | Not listed | $599.4k | 12/20/22 |